This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Pharma R&D Remove Research Related Topics
Pharmaceuticals Drug Development Regulations Drugs Therapies Treatment Disease Science Pharmaceutical Companies Government More Related Topics >
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

APRIL 24, 2024

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. The AI Act, which bans certain AI applications that it feels threaten citizens’ rights, was approved in the European Parliament in March 2024.

Pharma R&D 130
Pharma R&D Government Regulations Drug Development 130
article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

JANUARY 10, 2021

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.

Pharma R&D 40
Pharma R&D Pharmaceuticals Pharmaceutical Companies Disease 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024